Kara E. Geisel

Array ( [id] => 4359253 [patent_doc_number] => 06174910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'AT1 receptor antagonist for the stimulation of apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/142003 [patent_app_country] => US [patent_app_date] => 1998-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3464 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174910.pdf [firstpage_image] =>[orig_patent_app_number] => 142003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4132101 [patent_doc_number] => 06034088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Method and composition for inhibiting post-surgical adhesions' [patent_app_type] => 1 [patent_app_number] => 9/141122 [patent_app_country] => US [patent_app_date] => 1998-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7430 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034088.pdf [firstpage_image] =>[orig_patent_app_number] => 141122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152827 [patent_doc_number] => 06103487 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Method of treating cancer' [patent_app_type] => 1 [patent_app_number] => 9/140557 [patent_app_country] => US [patent_app_date] => 1998-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29552 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103487.pdf [firstpage_image] =>[orig_patent_app_number] => 140557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4090260 [patent_doc_number] => 06096337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Liquisolid systems and methods of preparing same' [patent_app_type] => 1 [patent_app_number] => 9/136035 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14539 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096337.pdf [firstpage_image] =>[orig_patent_app_number] => 136035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4345913 [patent_doc_number] => 06284730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Methods useful in the treatment of bone resorption diseases' [patent_app_type] => 1 [patent_app_number] => 9/125247 [patent_app_country] => US [patent_app_date] => 1998-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3017 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284730.pdf [firstpage_image] =>[orig_patent_app_number] => 125247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996153 [patent_doc_number] => 05985877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer' [patent_app_type] => 1 [patent_app_number] => 9/133567 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5660 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985877.pdf [firstpage_image] =>[orig_patent_app_number] => 133567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140728 [patent_doc_number] => 06060454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Compositions, apparatus and methods for facilitating surgical procedures' [patent_app_type] => 1 [patent_app_number] => 9/131075 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19427 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060454.pdf [firstpage_image] =>[orig_patent_app_number] => 131075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924910 [patent_doc_number] => 05945424 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Treatment of periodic limb movement syndrome' [patent_app_type] => 1 [patent_app_number] => 9/126819 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1982 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945424.pdf [firstpage_image] =>[orig_patent_app_number] => 126819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946554 [patent_doc_number] => 05977127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Cilansetron pharmaceutical preparation stabilized against racemization' [patent_app_type] => 1 [patent_app_number] => 9/126751 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4791 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977127.pdf [firstpage_image] =>[orig_patent_app_number] => 126751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157114 [patent_doc_number] => 06103769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Pharmaceutical composition containing nitric oxide' [patent_app_type] => 1 [patent_app_number] => 9/125085 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 3839 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103769.pdf [firstpage_image] =>[orig_patent_app_number] => 125085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235769 [patent_doc_number] => 06075044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases' [patent_app_type] => 1 [patent_app_number] => 9/118451 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6190 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075044.pdf [firstpage_image] =>[orig_patent_app_number] => 118451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147588 [patent_doc_number] => 06063797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => '.gamma.-RAR antagonist ligand or .alpha.-RAR agonist ligand as an apoptosis inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/051397 [patent_app_country] => US [patent_app_date] => 1998-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4536 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063797.pdf [firstpage_image] =>[orig_patent_app_number] => 051397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089518 [patent_doc_number] => 06133261 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Amino acid derivatives useful to treat stroke' [patent_app_type] => 1 [patent_app_number] => 9/116071 [patent_app_country] => US [patent_app_date] => 1998-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8624 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133261.pdf [firstpage_image] =>[orig_patent_app_number] => 116071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082661 [patent_doc_number] => 20020082281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY AGENTS THAT DISRUPT ACTIN CYTOSKELETAL ORGANIZATION' [patent_app_type] => new [patent_app_number] => 09/115387 [patent_app_country] => US [patent_app_date] => 1998-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21494 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082281.pdf [firstpage_image] =>[orig_patent_app_number] => 09115387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4128183 [patent_doc_number] => 06127425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Oral liquid medicine solution' [patent_app_type] => 1 [patent_app_number] => 9/106172 [patent_app_country] => US [patent_app_date] => 1998-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1796 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127425.pdf [firstpage_image] =>[orig_patent_app_number] => 106172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180015 [patent_doc_number] => 06037369 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Compounds obtained from salvia species having antiviral Activity' [patent_app_type] => 1 [patent_app_number] => 9/104363 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2895 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037369.pdf [firstpage_image] =>[orig_patent_app_number] => 104363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011162 [patent_doc_number] => 05962511 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Drugs for allergic and eosinophilic diseases' [patent_app_type] => 1 [patent_app_number] => 9/102088 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5048 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962511.pdf [firstpage_image] =>[orig_patent_app_number] => 102088 [rel_patent_id] =>[rel_patent_doc_number] =>)